Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/1993
05/04/1993US5208259 Diaryl ether hetrocycles
05/04/1993US5208251 Compounds for antiinflammatory agents, antiallergens, antiarthritic, antiulcer agents
05/04/1993US5208241 N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
05/04/1993US5208218 T cell growth factor glycoproteins
05/04/1993CA1317230C Aqueous preparation of 9-methyl-3-(1h-tetrazol-5-yl)- 4h-pyrido ¬1,2-a|pyrimidin-4-one potassium salt
04/1993
04/29/1993WO1993008284A1 M. paratuberculosis promoter and use thereof in immunogenic sequence expression
04/29/1993WO1993008280A1 Recombitope peptides
04/29/1993WO1993008279A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
04/29/1993WO1993008259A2 Inhibitors of dipeptidyl-aminopeptidase type iv
04/29/1993WO1993008215A1 Secreted mac-2-binding glycoprotein
04/29/1993WO1993008207A1 Novel cytokine
04/29/1993WO1993007900A1 In vitro antibody perfusion of kidney grafts
04/29/1993WO1993007899A1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS
04/29/1993WO1993007887A1 Combined cellular and immunosuppressive therapies
04/29/1993WO1993007863A1 Methods and compositions for treating allergic reactions
04/29/1993WO1993007856A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES
04/29/1993WO1993001165A3 Aromatic compounds, compositions containing them and their use in therapy
04/29/1993CA2121487A1 Combined cellular and immunosuppresive therapies
04/29/1993CA2121235A1 In vitro antibody perfusion of kidney grafts
04/29/1993CA2120911A1 Medicaments
04/28/1993EP0539330A1 Process for the preparation of substituted indoles
04/28/1993EP0539329A1 Acetenyl compounds useful as leukotrien antagonists
04/28/1993EP0539319A2 Pharmaceutical cyclosporin composition
04/28/1993EP0539117A1 Compounds useful as leukotriene antagonists
04/28/1993EP0538783A1 N-phenyl-2-cyano-3-hydroxycrotonic acid amid derivatives and their use as medicaments having immunomodulating properties
04/28/1993EP0538754A2 Use of antibody-containing preparations for immunosuppression
04/28/1993EP0538477A1 Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient
04/28/1993EP0538436A1 Novel quaternary ammonium salts, process for obtaining same and pharmaceutical compositions containing them
04/28/1993EP0538399A1 Cyclic cell adhesion modulation compounds
04/28/1993EP0538392A1 3-phenyl-5,6-dihydrobenz c]acridine-7-carboxylic acids and related compounds as immunosuppresive agents
04/28/1993EP0538384A1 Oxamides
04/28/1993EP0538330A1 Beta-alethine use in cell culture and therapy.
04/28/1993CN1071423A Bicyclic carboxylic acid derivatives
04/28/1993CN1071420A 4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl) phenyl)-5-methyl-3h-1,2,4-triazol-3-one derivatives
04/28/1993CN1071334A Solid for mulation containing amide derivative and process for preparing same
04/27/1993US5206345 Binding specifically to epitope of cell surface; monoclonal antibodies and antigen-binding fragments
04/27/1993US5206343 Oligopetides with cyclic proline-analogous amino acids
04/27/1993US5206255 Heterocyclic compound
04/27/1993US5206229 Inhibit cell proliferation, antiinflammatory, treating imbalance of immune system
04/27/1993US5206014 Activating antibody response
04/27/1993US5206008 Using androstene(diol or triol)
04/27/1993CA1316932C Methods and compositions for inhibiting lipoxygenase
04/27/1993CA1316929C Method of inhibiting virus
04/27/1993CA1316916C Hydroxide mediated fk-506 rearrangement product
04/27/1993CA1316649C Moulding contact lenses
04/26/1993CA2081303A1 Process for the preparation of substituted indoles
04/26/1993CA2081262A1 Acetylene compounds
04/25/1993CA2081133A1 Pharmaceutical compounds
04/24/1993CA2081173A1 N-phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property
04/21/1993EP0538000A1 Indole and indazole carbamates as leukotriene antagonists
04/21/1993EP0537949A1 Antiproliferative derivatives of 4H-naphtho 1,2-b pyran
04/21/1993EP0537354A1 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
04/21/1993EP0537353A1 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
04/21/1993EP0537293A1 Ligand for cd28 receptor on b cells and methods
04/21/1993EP0537269A1 Novel immunosuppressive compounds.
04/21/1993EP0537191A1 Treatment of organ transplantation rejection
04/21/1993EP0479871B1 Novel vitamin d analogues
04/21/1993EP0343248B1 Novel polypeptide and method for preparing the same
04/21/1993CN1071164A 含氮杂环化合物 Nitrogen-containing heterocyclic compounds
04/20/1993US5204446 Polypeptide having immunoreactivity with antibody specific to hepatitis b virus
04/20/1993US5204374 Cycloalkano(b)dihydroindoles and -indolesulphonamides substituted by heterocycles
04/20/1993US5204346 Pyrazolopyridine compounds
04/20/1993US5204338 Oxalylamino acid derivatives and their use as medicaments for inhibiting proline hydroxylase
04/20/1993US5204329 4-Quinoline carboxylic acid derivatives
04/20/1993CA1316534C Tetrahydronaphthaline and indane derivatives
04/20/1993CA1316459C Method of inhibiting virus
04/20/1993CA1316458C Pharmaceutical composition for piperidinoalkanol derivatives
04/18/1993CA2080405A1 Indole carbamates as leukotriene antagonists
04/15/1993WO1993007288A1 Macrophage activating factor from animal vitamin d-binding protein
04/15/1993WO1993007146A1 Benzo and pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity
04/15/1993WO1993007124A1 Nitrogenous heterocyclic compound
04/15/1993WO1993007111A1 Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity
04/15/1993WO1993006867A1 The regulation of systemic immune responses utilizing cytokines and antigens
04/15/1993WO1993006866A2 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
04/15/1993WO1993006864A1 Preventing allograft rejection with antibodies to adhesion molecules
04/15/1993WO1993006852A2 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein
04/15/1993WO1993006832A1 Method of treating hiv infection
04/15/1993WO1993006824A1 Preparations containing transition-metal compounds for anti-tumour therapy and/or stimulating the haematopoietic system
04/15/1993WO1993006812A2 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases
04/15/1993DE4134158A1 Verwendung von wasser- oder lipidloeslichen uebergangsmetallverbindungen pharmazeutische zubereitungen und verfahren zur herstellung pharmazeutischer zubereitungen fuer die antitumortherapie und/oder stimulierung des haematopoetischen systems Use of water or lipidloeslichen by transition metal compounds pharmaceutical preparations and process for manufacture of pharmaceutical preparations for the antitumor therapy and / or stimulation of the hematopoietic system
04/15/1993DE4134156A1 9-substituierte bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung 9-substituted bicyclo (3.3.0) octane derivatives, process for their production and their pharmaceutical use
04/15/1993DE4133694A1 Verwendung einer emulsion, zur herstellung eines arzneimittels zur iv-verabreichung zur behandlung von hauterkrankungen Use of an emulsion, for the manufacture of a medicament for intravenous administration for the treatment of skin diseases
04/15/1993CA2120500A1 Preventing allograft rejection with antibodies to adhesion molecules
04/15/1993CA2120351A1 Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity
04/15/1993CA2120140A1 Method of treating hiv infection
04/15/1993CA2116336A1 Nitrogenous heterocyclic compound
04/14/1993EP0537070A1 Compositions containing compound TMK688 and its analogs
04/14/1993EP0536896A1 Imidazolidyl macrolides having immunosuppressive activity
04/14/1993EP0536817A1 Azabicyclic compounds as tachykinin antagonists
04/14/1993EP0536807A1 Monoclonal antibodies and their use
04/14/1993EP0536564A2 Method to purify streptolysin O, intact streptolysin O obtainable by this method and its use
04/14/1993EP0536401A1 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
04/14/1993EP0536400A1 Tetrazole derivative and medicine
04/14/1993EP0536343A1 Targeted polymeric conjugates of cyclosporin and method for their preparation.
04/14/1993EP0536322A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a)
04/14/1993EP0536299A1 Surface complexed lymphotoxin
04/14/1993EP0536275A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
04/14/1993EP0536119A1 Immunoregulatory agents
04/14/1993CN1070910A Thiazolylbenzofuran derivatives, processes for preparation thereof and pharmaceutical composition comprising same
04/13/1993US5202422 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use